Alithea Genomics backgrounds in bioengineering, molecular biology, genomics and lab operations reflect their complementary expertise.
Alithea Genomics has raised €4.9M across 4 funding rounds from 7 investors, most recently a Seed round in Mar 2026. Based in Lausanne, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2026-03-06 | Seed | €3.3M | Genku Ventures,Novalis Biotech,Private Investors,Zürcher Kantonalbank | View deal → |
| 2023-03-21 | Debt | €502k | Foundation for Technological Innovation (FIT) | View deal → |
| 2022-05-25 | Other | €1.0M | Novalis Biotech Acceleration fund,Private Investors | View deal → |
| 2021-04-28 | Other | €136k | Venture Kick | View deal → |
